Tropical Journal of Pharmaceutical Research

Original Research Article | OPEN ACCESS

Identification of key genes and active components of Astragalus membranaceus in the treatment of colorectal cancer based on bioinformatics analysis

Lidi Xiang¹, Kongliang Ke¹, Chundi Miao¹, Jiajia Sun², Luqing Zhang¹

¹Department of General Surgery; ²Department of Intensive Care Unit, Ningbo Hangzhou Bay Hospital, 1155 Binhai 2nd Road, Qianwan New Area, Ningbo City, Zhejiang Province 315327, China.

For correspondence:- Luqing Zhang Email: lulu3114@163.com

Accepted: 6 November 2022 Published: 29 December 2022

Citation: Xiang L, Ke K, Miao C, Sun J, Zhang L. Identification of key genes and active components of Astragalus membranaceus in the treatment of colorectal cancer based on bioinformatics analysis. Trop J Pharm Res 2022; 21(12):2645-2650 doi: 10.4314/tjpr.v21i12.20

© 2022 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

urpose: To investigate the bio-active components and key targets of Astragalus membranaceus (AM) in the treatment of colorectal cancer (CRC) through bioinformatics analysis.

Methods: An AM action network was constructed after taking intersection of the target genes in AM and CRC-related genes. After that, Protein-Protein Interaction analysis, Gene Ontology enrichment analysis and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis were performed on the intersected genes. Then, the differential genes in GSE70772 and GSE113513 datasets were screened separately and intersected with genes from the PPI analysis to obtain the key targets.

Results: After intersection with potential targets of AM and CRC-related genes, 105 genes were screened by PPI analysis. Then, 20 genes were identified as potential target genes of AM in GSE70772 and GSE113513 datasets. These genes were intersected with the 105 genes. Finally, a key gene called MET was identified as the key target of action of AM in the treatment of CRC, and methylnissolin (MOL000380) was the active component of AM.

Conclusion: MET a potential key target gene of AM, whose active component is methylnissolin, in the treatment of CRC. Thus, the findings of this study may provide a scientific basis for the further development of AM for the treatment of CRC.

Keywords: Â Astragalus membranaceus, colorectal cancer, tumor, bioinformatics analysis, target gene